{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:28:54Z","timestamp":1757618934925,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Young Eagle Project of PUTH","award":["none"],"award-info":[{"award-number":["none"]}]},{"name":"National Key Research and Development Program of China","award":["2021"],"award-info":[{"award-number":["2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02683-y","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:50:07Z","timestamp":1752605407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic radiotherapy with Gamma Master System\u00ae for palliation of hepatocellular carcinoma in patients with liver cirrhosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Bin","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"2683_CR1","unstructured":"NCCN Guidelines Version 4. 2024 Hepatocellular Carcinoma. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1514."},{"key":"2683_CR2","doi-asserted-by":"crossref","unstructured":"Villanueva A, Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","DOI":"10.1056\/NEJMra1713263"},{"issue":"10360","key":"2683_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"2","key":"2683_CR4","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.3390\/curroncol30020190","volume":"30","author":"Y Matsuo","year":"2023","unstructured":"Matsuo Y. Stereotactic body radiotherapy for hepatocellular carcinoma: a brief overview. Curr Oncol. 2023;30(2):2493\u2013500.","journal-title":"Curr Oncol"},{"key":"2683_CR5","doi-asserted-by":"crossref","unstructured":"Bae SH, Chun SJ, Chung JH, Kim E, Kang JK, Jang WI, Moon JE, Roquette I, Mirabel X, Kimura T, Ueno M, Su TS, Tree AC, Guckenberger M, Lo SS, Scorsetti M, Slotman BJ, Kotecha R, Sahgal A, Louie AV, Kim MS. Stereotactic body radiation therapy for hepatocellular carcinoma: meta-analysis and international stereotactic radiosurgery society practice guidelines. Int J Radiat Oncol Biol Phys 2023.","DOI":"10.1016\/j.ijrobp.2023.08.015"},{"issue":"43","key":"2683_CR6","doi-asserted-by":"publisher","first-page":"12439","DOI":"10.3748\/wjg.v21.i43.12439","volume":"21","author":"B Qiu","year":"2015","unstructured":"Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World J Gastroenterol. 2015;21(43):12439\u201347.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"2683_CR7","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00270-017-1655-8","volume":"40","author":"B Qiu","year":"2017","unstructured":"Qiu B, Li K, Dong X, Liu FQ. Transjugular intrahepatic portosystemic shunt for portal hypertension in hepatocellular carcinoma with portal vein tumor Thrombus. Cardiovasc Intervent Radiol. 2017;40(9):1372\u201382.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"2683_CR8","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"2683_CR9","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","volume":"21","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Wong G, Anstee QM, Henry L. The global burden of liver disease. Clin Gastroenterol Hepatol. 2023;21(8):1978\u201391.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2683_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijrobp.2022.09.052","volume":"115","author":"A Juloori","year":"2023","unstructured":"Juloori A, Katipally RR, Lemons JM, Singh AK, Iyer R, Robbins JR, George B, Hall WA, Pitroda SP, Arif F, Fung J, Pillai A, Liao CY, Sharma M, Liauw SL. Phase 1 randomized trial of stereotactic body radiation therapy followed by nivolumab plus ipilimumab or nivolumab alone in advanced\/unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2023;115(1):202\u201313.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2683_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm12103517","volume":"12","author":"Y Liu","year":"2023","unstructured":"Liu Y, Chou B, Yalamanchili A, Lim SN, Dawson LA, Thomas TO. Local therapies for hepatocellular carcinoma and role of MRI-guided adaptive radiation therapy. J Clin Med. 2023;12:10.","journal-title":"J Clin Med"},{"issue":"1","key":"2683_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijrobp.2023.03.064","volume":"117","author":"A Mendez Romero","year":"2023","unstructured":"Mendez Romero A, van der Holt B, Willemssen F, de Man RA, Heijmen BJM, Habraken S, Westerveld H, van Delden OM, Klumpen HJ, Tjwa E, Braam PM, Jenniskens SFM, Vanwolleghem T, Weytjens R, d\u2019Archambeau O, de Vos-Geelen J, Buijsen J, van der Leij C, den Toom W, Sprengers D, JNM IJ, Moelker A. Transarterial chemoembolization with drug-eluting beads versus stereotactic body radiation therapy for hepatocellular carcinoma: outcomes from a multicenter, randomized, phase 2 trial (the TRENDY trial). Int J Radiat Oncol Biol Phys. 2023;117(1):45\u201352.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2683_CR13","doi-asserted-by":"crossref","unstructured":"Lee VH, Vardhanabhuti V, Wong TC, Lam KO, Choi HC, Chiu KW, Ho PP, Leung DK, Szeto MH, Choi KF, Chan SC, Leung TW, Khong PL, Lo CM. Stereotactic body radiotherapy and liver transplant for liver cancer: a nonrandomized controlled trial. JAMA Netw Open. 2024;7(6):e2415998.","DOI":"10.1001\/jamanetworkopen.2024.15998"},{"issue":"10","key":"2683_CR14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/09553002.2022.2055800","volume":"98","author":"A Srivastava","year":"2022","unstructured":"Srivastava A, Parambath HK, Ramdulari AV, Saxena H, Kumar R, Pandey S, Shalimar; Gupta S, Jee B. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy? Int J Radiat Biol. 2022;98(10):1495\u2013509.","journal-title":"Int J Radiat Biol"},{"key":"2683_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12962-019-0198-z","volume":"18","author":"H Wang","year":"2020","unstructured":"Wang H, Jin C, Fang L, Sun H, Cheng W, Hu S. Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review. Cost Eff Resour Alloc. 2020;18:1.","journal-title":"Cost Eff Resour Alloc"},{"key":"2683_CR16","doi-asserted-by":"publisher","first-page":"882272","DOI":"10.3389\/fonc.2022.882272","volume":"12","author":"F Fang","year":"2022","unstructured":"Fang F, Qiu B, Zhen P, Wang J. Hypofractionated radiotherapy for palliation of main portal vein tumor thrombosis. Front Oncol. 2022;12:882272.","journal-title":"Front Oncol"},{"issue":"5","key":"2683_CR17","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaad.2012.02.010","volume":"67","author":"AP Chen","year":"2012","unstructured":"Chen AP, Setser A, Anadkat MJ, Cotliar J, Olsen EA, Garden BC, Lacouture ME. Grading dermatologic adverse events of cancer treatments: the common terminology criteria for adverse events version 4.0. J Am Acad Dermatol. 2012;67(5):1025\u201339.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2683_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ijrobp.2023.08.015","volume":"118","author":"SH Bae","year":"2024","unstructured":"Bae SH, Chun SJ, Chung JH, Kim E, Kang JK, Jang WI, Moon JE, Roquette I, Mirabel X, Kimura T, Ueno M, Su TS, Tree AC, Guckenberger M, Lo SS, Scorsetti M, Slotman BJ, Kotecha R, Sahgal A, Louie AV, Kim MS. Stereotactic body radiation therapy for hepatocellular carcinoma: meta-analysis and international stereotactic radiosurgery society practice guidelines. Int J Radiat Oncol Biol Phys. 2024;118(2):337\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2683_CR19","doi-asserted-by":"crossref","unstructured":"Cai Y, Chang Q, Xiao E, Shang QL, Chen Z. Transcatheter arterial chemoembolization (TACE) combined with gamma-knife compared to TACE or gamma-knife alone for hepatocellular carcinoma. Med (Baltim). 2018;97(22):e10890.","DOI":"10.1097\/MD.0000000000010890"},{"issue":"1","key":"2683_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jocn.2014.08.012","volume":"22","author":"JP Caruso","year":"2015","unstructured":"Caruso JP, Moosa S, Fezeu F, Ramesh A, Sheehan JP. A cost comparative study of gamma knife radiosurgery versus open surgery for intracranial pathology. J Clin Neurosci. 2015;22(1):184\u20138.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2683_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00423-024-03249-4","volume":"409","author":"T Bai","year":"2024","unstructured":"Bai T, Tang ZH, Wang XB, Chen J, Ye JZ, Lu SL, Wei M, Wu FX, Li LQ. Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: a single-center prospective randomized study. Langenbecks Arch Surg. 2024;409(1):97.","journal-title":"Langenbecks Arch Surg"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02683-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:04:59Z","timestamp":1757243099000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02683-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2683"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02683-y","relation":{},"ISSN":["1748-717X"],"issn-type":[{"type":"electronic","value":"1748-717X"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The retrospective study was approved by the Chifeng Tumor Hospital institutional review board following the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"110"}}